ROCHESTER, Minn. (KTTC) -- Mayo Clinic is reporting some positive results from its convalescent plasma treatment for hospitalized COVID-19 patients.
According to a news release Friday, researchers report the 35,322 patients enrolled in the Expanded Access Program (EAP) study were associated with a lower mortality rate over a three month period.
There was a high proportion of critically ill patients, including 52.3 percent in an intensive care unit. 27.5 percent were on ventilators at the time of plasma transfusion.
The study noted the seven day mortality rate was reduced in patients who have received a transfusion within three days of a COVID-19 diagnosis when compared to those transfused four or more day after being diagnosed.
The data in this study was collected between April 4th and July 4th with participants who were hospitalized with or were at risk of severe or life-threatening acute COVID-19 respiratory syndrome.